Related Experiment Video
Updated: Feb 6, 2026

Perspectives on Neuroscience
Published on: July 31, 2007
New Multitarget Approaches in the War Against Glioblastoma: A Mini-Perspective
Simona Sestito1, Massimiliano Runfola1, Marco Tonelli2
1Department of Pharmacy, University of Pisa, Pisa, Italy.
Abstract:
Glioblastoma multiforme (GBM) is the most common tumor of the CNS, and the deadliest form of brain cancer. The rapid progression, the anatomic location in the brain and a deficient knowledge of the pathophysiology, often limit the effectiveness of therapeutic interventions. Current pillars of GBM therapies include surgical resection, radiotherapy and chemotherapy, but the low survival rate and the short life expectation following these treatments strongly underline the urgency to identify innovative and more effective therapeutic tools. Frequently, patients subjected to a mono-target therapy, such as Temozolomide (TMZ), develop drug resistance and undergo relapse, indicating that targeting a single cellular node is not sufficient for eradication of this disease. In this context, a multi-targeted therapeutic approach aimed at using compounds, alone or in combination, capable of inhibiting more than one specific molecular target, offers a promising alternative. Such strategies have already been well integrated into drug discovery campaigns, including in the field of anticancer drugs. In this miniperspective, we will discuss the recent progress in the treatment of GBM focusing on innovative and effective preclinical strategies, which are based on a multi-targeted approach.
Insights
Glioblastoma multiforme (GBM) is a deadly brain cancer. Multi-targeted therapies show promise against GBM, overcoming resistance seen with single-drug treatments like Temozolomide (TMZ).
Area of Science:
- Neuro-oncology
- Cancer Therapeutics
- Molecular Biology
Background:
- Glioblastoma multiforme (GBM) is the most prevalent and lethal primary brain tumor.
- Current treatments (surgery, radiation, chemotherapy) offer limited efficacy and survival rates.
- Drug resistance, particularly to Temozolomide (TMZ), necessitates novel therapeutic strategies.
Purpose of the Study:
- To review innovative preclinical strategies for Glioblastoma multiforme (GBM) treatment.
- To highlight the potential of multi-targeted therapeutic approaches in overcoming GBM resistance.
- To discuss advancements in anticancer drug discovery for brain tumors.
Main Methods:
- Review of recent preclinical research in GBM therapy.
- Focus on multi-targeted strategies inhibiting multiple molecular pathways.
- Analysis of drug resistance mechanisms and combination therapies.
Main Results:
- Single-agent therapies like Temozolomide (TMZ) frequently lead to drug resistance and relapse.
- Multi-targeted approaches demonstrate potential for enhanced efficacy in preclinical models.
- Combination therapies targeting multiple molecular nodes offer a promising alternative to monotherapy.
Conclusions:
- A multi-targeted therapeutic strategy is a promising avenue for overcoming Glioblastoma multiforme (GBM) resistance.
- Innovative preclinical research is crucial for developing more effective brain cancer treatments.
- Targeting multiple molecular pathways represents a significant advancement in Glioblastoma multiforme (GBM) drug discovery.
Related Concept Videos
Psychodynamic Perspectives on Personality
Psychodynamic theorists argue that unconscious...
Criticisms of the Evolutionary Perspective
Evolutionary psychology provides one explanation for these findings, suggesting...
The Behavioral Perspective on Personality
Social Cognitive Perspective on Personality
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Carl Rogers' Humanistic Perspective on Personality
The organism refers to an individual's inherent blueprint, which Rogers saw as innately positive and directed toward helping others, unlike Freud's view of the id as driven by base impulses. The self is a person's...

